Outsourcing Outlook

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-06-02-2002, Volume 26, Issue 6

The author discusses the upcoming human research congressional debate and CROs' preparations to respond.

Related Content:

Bio/Pharma BusinessOutsourcingManufacturingOutsourcing OutlookContract Manufacturing, GeneralPharmaceutical Technology-06-02-2002
Increasing mRNA Product Stability with Lyophilization
Bristol Myers Squibb to Access Cellares' Cell Therapy Manufacturing Platform in New $380 Million CAR-T Cell Therapy Deal
INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities